Skip to content

"Just one bad high:" considering synthetic cannabinoid outcome expectancies in adolescents.

David S. Mathai, Christopher D. Verrico, Daryl Shorter, John H Coverdale, Thomas R Kosten

American Journal on Addictions December 2016 DOI: 10.1111/ajad.12457 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case study Case report Peer reviewed
Sample size 1
Population An 18-year-old male adolescent who used synthetic cannabinoids
Key findings The authors propose that adolescents' drug expectancies may minimize the severity of synthetic cannabinoid-related adverse events, possibly reflecting generalizations from cannabis. The reported patient, despite counseling, planned to resume synthetic cannabinoid use and described his hospitalization as 'just one bad high,' leading the authors to argue that interventions should counter cannabis-related expectancies of minimal harm.

Abstract

Certain medical consequences seem unique to synthetic cannabinoid (SC) and not cannabis use. We report the case of an adolescent, whose drug expectancies appear to minimize the severity of SC-related adverse events. An 18-year-old male presented with altered mental status and seizure, complicated by respiratory failure. He was stabilized and on discharge, despite counseling on the harms of SC usage, the patient planned to resume use, insisting that the hospitalization was "just one bad high". Diminished negative expectancies related to SC use among adolescents may reflect generalizations from cannabis. Effective interventions should counter cannabis-related expectancies of minimal harm. (Am J Addict 2016;XX:1-3).

Citations in the library

Explore topics